Marvel Biosciences Corp Stock Current Valuation
| MRVL Stock | 0.18 0.01 5.88% |
Valuation analysis of Marvel Biosciences Corp helps investors to measure Marvel Biosciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -1.52 in 2024. Enterprise Value Multiple is likely to drop to -1.52 in 2024. Fundamental drivers impacting Marvel Biosciences' valuation include:
Price Book 226.8162 | Enterprise Value 8.7 M | Enterprise Value Ebitda (1.39) |
Overvalued
Today
Please note that Marvel Biosciences' price fluctuation is out of control at this time. Calculation of the real value of Marvel Biosciences Corp is based on 3 months time horizon. Increasing Marvel Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Marvel stock is determined by what a typical buyer is willing to pay for full or partial control of Marvel Biosciences Corp. Since Marvel Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Marvel Stock. However, Marvel Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.18 | Real 0.13 | Hype 0.18 | Naive 0.19 |
The intrinsic value of Marvel Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Marvel Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Marvel Biosciences Corp helps investors to forecast how Marvel stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Marvel Biosciences more accurately as focusing exclusively on Marvel Biosciences' fundamentals will not take into account other important factors: Marvel Biosciences Corp Company Current Valuation Analysis
Marvel Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Marvel Biosciences Current Valuation | 8.67 M |
Most of Marvel Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Marvel Biosciences Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Marvel Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Marvel Biosciences is extremely important. It helps to project a fair market value of Marvel Stock properly, considering its historical fundamentals such as Current Valuation. Since Marvel Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Marvel Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Marvel Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Marvel Biosciences Corp has a Current Valuation of 8.67 M. This is 99.94% lower than that of the Biotechnology sector and 99.81% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.95% higher than that of the company.
Marvel Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Marvel Biosciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Marvel Biosciences could also be used in its relative valuation, which is a method of valuing Marvel Biosciences by comparing valuation metrics of similar companies.Marvel Biosciences is currently under evaluation in current valuation category among its peers.
Marvel Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Marvel Biosciences from analyzing Marvel Biosciences' financial statements. These drivers represent accounts that assess Marvel Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Marvel Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.9M | 4.2M | 2.8M | 3.2M | 2.9M | 2.3M | |
| Enterprise Value | 2.6M | 1.9M | 2.2M | 3.6M | 3.3M | 1.8M |
Marvel Fundamentals
| Return On Equity | -3.8 | ||||
| Return On Asset | -1.54 | ||||
| Current Valuation | 8.67 M | ||||
| Shares Outstanding | 44.79 M | ||||
| Shares Owned By Insiders | 26.66 % | ||||
| Number Of Shares Shorted | 18 | ||||
| Price To Book | 226.82 X | ||||
| EBITDA | (2.19 M) | ||||
| Net Income | (2.29 M) | ||||
| Total Debt | 2.39 M | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (1.33 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 7.39 M | ||||
| Total Asset | 672.39 K | ||||
| Retained Earnings | (9.05 M) | ||||
| Working Capital | (720.09 K) | ||||
| Net Asset | 672.39 K |
About Marvel Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Marvel Biosciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Marvel Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Marvel Biosciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.